首页> 外文OA文献 >Epithelial-Specific Methylation Marker: A Potential Plasma Biomarker in Advanced Non-small Cell Lung Cancer

【2h】

Epithelial-Specific Methylation Marker: A Potential Plasma Biomarker in Advanced Non-small Cell Lung Cancer

机译：上皮特异性甲基化标记：晚期非小细胞肺癌的潜在血浆生物标记。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Vinayanuwattikun Chanida; Sriuranpong Virote; Tanasanvimon Suebpong; Chantranuwat Poonchavist; Mutirangura Apiwat;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer. [J] . Vinayanuwattikun C, Sriuranpong V, Tanasanvimon S, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2011,第11期

机译：上皮特异性甲基化标记物：晚期非小细胞肺癌的潜在血浆生物标记物。
2. P2.01-23 Baseline Plasma Biomarkers Predict Long-Term Responses to ALK-TKIs in ALK+ Advanced Non-Small Cell Lung Cancer (NSCLC) [J] . M. Couetoux Du Tertre, M. Marques, L. Izzi, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第10期

机译：P2.01-23基线等离子体生物标志物预测Alk +晚期非小细胞肺癌（NSCLC）的KAL-TKIS的长期反应
3. Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab [J] . Adrien Costantini, Catherine Julie, Coraline Dumenil, Oncoimmunology. . 2018,第8期

机译：血浆生物标志物在Nivolumab治疗晚期非小细胞肺癌中的预测作用
4. An Integrated Approach for Profiling Potential Biomarkers in Human Plasma to Detection Non-small Cell Lung Cancer [C] . Valeriy E. Shevchenko, Irina B. Zborovskaya, Natalia E. Arnotskaya, ASMS Conference on Mass Spectrometry and Allied Topics . 2006

机译：一种分析人血浆中潜在生物标志物检测非小细胞肺癌的综合方法
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Plasma thymidylate synthase and dihydrofolate reductase mRNA levels as potential predictive biomarkers of pemetrexed sensitivity in patients with advanced non-small cell lung cancer [O] . Tao Li, Jin-Bo Huang, Jun-Guo Lu, 2020

机译：血浆胸苷晶酯合酶和二氢脱液还原酶mRNA水平作为晚期非小细胞肺癌患者患者的潜在预测生物标志物
7. Plasma thymidylate synthase and dihydrofolate reductase mRNA levels as potential predictive biomarkers of pemetrexed sensitivity in patients with advanced non-small cell lung cancer [O] . Tao Li, Jin-Bo Huang, Jun-Guo Lu, 2020

机译：血浆胸苷晶酯合酶和二氢脱液还原酶mRNA水平作为晚期非小细胞肺癌患者患者的潜在预测生物标志物

Epithelial-Specific Methylation Marker: A Potential Plasma Biomarker in Advanced Non-small Cell Lung Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅